Based on a conference sponsored by the Comprehensive Center for Translational Research on Human Immunology and Biodefense at the Emory Vaccine Center (EVC), Emory University. The EVC is one of eight institutions that received funding from the National Institutes of Health to establish a Comprehensive Center for Translational Research on Human Immunology and Bio-defense (CCHI). The long-term goal of the CCHI program is the translation of research into clinical applications in humans. Immediate goals are to support basic and translational research on human immunological responses to NIAID Category A, B or C priority pathogens, their toxins, or other emerging or re-emerging infectious diseases.

Special online volume with free access to all articles